Kikuchi Noriko, Shiga Tsuyoshi, Suzuki Atsushi, Hagiwara Nobuhisa
Department of Cardiology, Tokyo Women's Medical University, Tokyo, Japan.
Department of Clinical Pharmacology and Therapeutics, The Jikei University School of Medicine, Tokyo, Japan.
Int J Cardiol Heart Vasc. 2020 Nov 6;31:100669. doi: 10.1016/j.ijcha.2020.100669. eCollection 2020 Dec.
Atrial tachyarrhythmias (ATAs) are associated with an increased risk of incident heart failure (HF). The aim of this study was to evaluate the incidence of ATAs and time of ATA development during disease progression as well as the influence of ATAs on HF-related events in patients with arrhythmogenic right ventricular cardiomyopathy (ARVC).
We retrospectively studied 90 ARVC patients who met the definitive diagnosis of the 2010 Task Force Criteria and were diagnosed with ARVC at our institutions between 1974 and 2012. The main outcomes were death due to HF and hospitalization due to worsening HF.
Eleven patients had a history of ATAs at the time of ARVC diagnosis. Of 79 patients without a prediagnosis history of ATAs, 21 (27%) newly experienced ATAs during a median follow-up period of 11.4 (range, 0.1-29.6) years. Among them, 15 patients experienced their first hospitalization due to worsening HF a median of 1.7 (range, 0.0-9.8) years after the occurrence of ATAs. Patients with ATAs were more likely to experience death due to HF and hospitalization due to worsening HF than patients without ATAs (odds ratio 19.2, 95% confidence interval 2.0-92.3, P < 0.01 and odds ratio 29.7, 95% confidence interval 8.4-104.8, P < 0.01, respectively). Multivariable analysis revealed that ATAs were associated with an increased risk of hospitalization due to worsening HF (hazard ratio 15.55, 95% confidence interval 4.82-50.17, P < 0.01).
Our study suggests that the occurrence of ATAs is associated with an increased risk of HF-related events and worsens the prognosis of ARVC patients.
房性快速性心律失常(ATA)与新发心力衰竭(HF)风险增加相关。本研究旨在评估致心律失常性右室心肌病(ARVC)患者疾病进展过程中ATA的发生率、ATA发生时间以及ATA对HF相关事件的影响。
我们回顾性研究了90例符合2010年工作组标准确诊诊断且于1974年至2012年间在我们机构被诊断为ARVC的患者。主要结局为HF导致的死亡和HF恶化导致的住院。
11例患者在ARVC诊断时即有ATA病史。在79例无ATA诊断前病史的患者中,21例(27%)在中位随访期11.4年(范围0.1 - 29.6年)内新发ATA。其中,15例患者在ATA发生后中位1.7年(范围0.0 - 9.8年)因HF恶化首次住院。有ATA的患者比无ATA的患者更易发生HF导致的死亡和HF恶化导致的住院(优势比分别为19.2,95%置信区间2.0 - 92.3,P < 0.01和优势比29.7,95%置信区间8.4 - 104.8,P < 0.01)。多变量分析显示,ATA与HF恶化导致的住院风险增加相关(风险比15.55,95%置信区间4.82 - 50.17,P < 0.01)。
我们的研究表明,ATA的发生与HF相关事件风险增加相关,并使ARVC患者的预后恶化。